These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1299786)

  • 21. Role of anti-basement membrane immunity in human glomerulonephritis.
    Bach JF; Dardenne M; Hinglais N; Mahieu P
    Adv Nephrol Necker Hosp; 1972; 2():75-94. PubMed ID: 4219697
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-glomerular basement membrane antibody-induced glomerulonephritis without pulmonary hemorrhage; report of a case].
    Fujioka M; Nakamoto Y; Dohi K; Kida H; Yuri T
    Nihon Jinzo Gakkai Shi; 1975 Jul; 17(7):611-8. PubMed ID: 1241398
    [No Abstract]   [Full Text] [Related]  

  • 23. Dense deposit disease: a subgroup of membranoproliferative glomerulonephritis, identified by electron microscopy.
    MacDonald MK
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():515-30. PubMed ID: 4620925
    [No Abstract]   [Full Text] [Related]  

  • 24. Serologic evaluation of renal status.
    McPherson RA
    Clin Lab Med; 1993 Mar; 13(1):69-87. PubMed ID: 8462270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of a radio-immunoassay for auto-antibodies to glomerular basement membrane.
    Bowman C; Lockwood CM
    J Clin Lab Immunol; 1985 Aug; 17(4):197-202. PubMed ID: 4068032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An experimental model relevant to recurrent autoimmune glomerulonephritis in transplanted human kidneys.
    Steblay RW; Rudofsky U
    Transplant Proc; 1969 Mar; 1(1):609-13. PubMed ID: 4944278
    [No Abstract]   [Full Text] [Related]  

  • 27. Pathogenic significance of ANCA in a patient with crescentic glomerulonephritis, bone marrow granulomata, and linear staining pattern along the glomerular basement membrane with ANCA by indirect immunofluorescence.
    Sepandj F; Cohen B; Gupta R
    Nephrol Dial Transplant; 1997 Dec; 12(12):2698-702. PubMed ID: 9430875
    [No Abstract]   [Full Text] [Related]  

  • 28. [Circulating immune complexes and glomerulopathies].
    Richet G; Rouques R
    Ann Biol Clin (Paris); 1971; 29(1):1-3. PubMed ID: 4931372
    [No Abstract]   [Full Text] [Related]  

  • 29. [History of nephrology in the last 100 years: Acute rapidly progressive glomerulonephritis].
    Koyama A; Hirayama K
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1479-83. PubMed ID: 12082738
    [No Abstract]   [Full Text] [Related]  

  • 30. What are sensitized cells doing in glomerulonephritis?
    Dixon FJ
    N Engl J Med; 1970 Sep; 283(10):536-7. PubMed ID: 5434140
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro and in vivo properties of autoantibodies eluted from kidneys of sheep with autoimmune glomerulonephritis.
    Steblay RW; Rudofsky U
    Nature; 1968 Jun; 218(5148):1269-71. PubMed ID: 4872219
    [No Abstract]   [Full Text] [Related]  

  • 32. The spectrum of renal diseases associated with anti-basement membrane antibodies.
    Senekjian HO; Knight TF; Weinman EJ
    Arch Intern Med; 1980 Jan; 140(1):79-81. PubMed ID: 6986125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful renal transplantation in patients with circulating antibodies to glomerular basement membrane.
    Couser WG; Monaco AP; Lewis EJ
    Proc Clin Dial Transplant Forum; 1973; 3():208-10. PubMed ID: 4619684
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary structure of the glycopeptide responsible for autoimmunity against the glomerular basement membrane in the human glomerulonephritis].
    Mahieu P; Maghuin-Rogister G
    Arch Int Physiol Biochim; 1973 Feb; 81(1):194-5. PubMed ID: 4122924
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma exchange in rapidly progressive glomerulonephritis.
    Cole E
    Prog Clin Biol Res; 1990; 337():257-62. PubMed ID: 2191318
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing pattern of glomerulonephritis in the elderly: a change of prevalence or a different approach?
    Bergesio F; Bertoni E; Bandini S; Rosati A; Salvadori M
    Contrib Nephrol; 1993; 105():75-80. PubMed ID: 8252875
    [No Abstract]   [Full Text] [Related]  

  • 37. Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats.
    Sado Y; Naito I; Okigaki T
    J Pathol; 1989 Aug; 158(4):325-32. PubMed ID: 2769491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological, ultrastructural and immunofluorescence studies in membranoproliferative glomerulonephritis.
    Nagi AH
    J Pathol; 1972 Mar; 106(3):151-4. PubMed ID: 4114030
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical immunology and immunopathology of glomerulonephritis (author's transl)].
    Lanzer G; Syré G
    Wien Klin Wochenschr; 1980 Sep; 92(18):631-8. PubMed ID: 6451083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimyeloperoxidase antibodies in elderly females with severe antiglomerular basement membrane disease.
    O'Donoghue DJ; Vanhille P; Lesavre P; Noel LH
    Nephrol Dial Transplant; 1992; 7(5):454-5. PubMed ID: 1321386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.